Hjem › Makuladegeneration › North Carolina
Makuladegeneration kliniske forsøg i North Carolina
11 studier for Makuladegeneration søger deltagere på steder i North Carolina.
Byer i North Carolina
Officiel studietekst (engelsk)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Piedmont Retina Specialists - Greensboro, Greensboro
- North Carolina Retina Associates, Greenville
- Piedmont Retina Specialists - Winston-Salem, Winston-Salem
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Asheville Eye Associates - Western Carolina Retinal Associates, Asheville
- Duke Eye Center, Durham
- Graystone Eye, Hickory
- og 1 flere
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NC Retina Associates, Cary
- Graystone Eye, Hickory
- North Carolina Retina Associates, Wake Forest
- og 1 flere
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- North Carolina Retina Associates, Cary
- Duke Eye Center, Durham
- North Carolina Retina Associates, Greenville
- og 1 flere
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- Duke Eye Center, Durham
RekruttererObservationsstudie
Alder 55 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07144137A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Duke Eye Center, Durham
RekruttererObservationsstudie
Alder 6 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07425574AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
- Duke Eye Center, Durham
RekruttererFrivillige med god helbredstilstand velkomne
Alder 50 til 89 · Alle køn · Opdateret 10. aug. 2026 · NCT06619405A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Asheville Eye Associates, Retina Division (Site 077), Asheville
- NC Retina, Cary
- Graystone Eye, Hickory
- og 1 flere
RekruttererFase 2/3
Alder 50 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT07496567Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
- Wake Forest, NC, Wake Forest
RekruttererFase 1/2
Alder 50 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07587515Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- North Carolina Retina Associates, Cary
- North Carolina Retina Associates, Wake Forest
RekruttererFase 3
Alder 50 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Western Carolina Retinal Associates, Asheville
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.